does semaglutide increase risk of blood clots Wegovy and Clots: Do GLP-1 Drugs Your DVT and PE? Does Wegovy Increase the Risk

GLP-1 cardiovascular outcomes Multiple large-scale cardiovascular outcomes trials have demonstrated that GLP-1 agonists reduce the risk of major adverse cardiovascular events, including heart attack, stroke, and cardiovascular death

Starting with lower doses and gradually increasing can help minimize potential side effects

Thats why its so important to seek personalized advice and support from your clinician throughout your weight-loss journey

Skin texture improves as new collagen forms under the surface

Currently, there is limited research specifically detailing interactions between GLP-1 receptor agonists and hormonal treatments for endometriosis